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Available online 26 October 2016Rationale: Cholesteryl hemiesters are oxidation products of polyunsaturated fatty acid esters of cholesterol. Their
oxo-ester precursors have been identiﬁed as important components of the “core aldehydes” of human atheroma-
ta and in oxidized lipoproteins (Ox-LDL). We had previously shown, for the ﬁrst time, that a single compound of
this family, cholesteryl hemisuccinate (ChS), is sufﬁcient to cause irreversible lysosomal lipid accumulation
(lipidosis), and is toxic to macrophages. These features, coupled to others such as inﬂammation, are typically
seen in atherosclerosis.
Objective: To obtain insights into the mechanism of cholesteryl hemiester-induced pathological changes in
lysosome function and induction of inﬂammation in vitro and assess their impact in vivo.
Methods and results:Wehave examined the effects of ChS onmacrophages (murine cell lines and primary cultures)
in detail. Speciﬁcally, lysosomalmorphology, pH, andproteolytic capacitywere examined. Exposure ofmacrophages
to sub-toxic ChS concentrations caused enlargement of the lysosomes, changes in their luminal pH, and accumula-
tion of cargo in them. In primarymouse bonemarrow-derivedmacrophages (BMDM), ChS-exposure increased the
secretion of IL-1β, TNF-α and IL-6. In zebraﬁsh larvae (wild-type AB and PU.1:EGFP), fed with a ChS-enriched diet,
we observed lipid accumulation, myeloid cell-inﬁltration in their vasculature and decrease in larval survival.
Under the same conditions the effects of ChS were more profound than the effects of free cholesterol (FC).
Conclusions:Our data strongly suggest that cholesteryl hemiesters are pro-atherogenic lipids able to mimic features
of Ox-LDL both in vitro and in vivo.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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The factors that initiate atherosclerotic lesions and inﬂuence their
progression are extremely complex and still relatively poorly under-
stood [1]. One of the early distinguishing characteristics of the process,
already described by deDuve and Peters in the 1970s [2], is thepresence
of macrophage-derived foam cells in the arterial wall. They result from
ingestion of lipid accumulated in the vascular wall by the macrophages
and storage of these lipids in lipid droplets,which leads to the formation
of intravascular “fatty streaks”. This process is, initially, reversible.
However, with time, the internalized lipid cannot be metabolically
processed by macrophages, and accumulates in their lysosomal com-
partment resulting in an irreversible phenotype that has the character-
istics of lipidosis manifested in several lipid storage diseases [3,4].
Importantly, the exact molecular mechanisms involved in lysosomal
lipid accumulation have not been identiﬁed. There is a consensus that
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(LDL) within the arterial intima followed by some modiﬁcation of
the entrapped LDL particles [5]. One modiﬁcation that LDL particles
undergo in the arterial intima is oxidation [6–11]. This modiﬁcation is
important because it allows macrophages to take up these particles
through unregulated scavenger receptor pathways [5] or through
macropinocytosis [12].
Cholesteryl hemiesters are oxidation products of the core aldehydes
present in human atheromata [13] and also in oxidized LDL (Ox-LDL)
[14]. So far, although considerable attention has been paid in the litera-
ture to the atherogenicity of oxidized phospholipids [15,16] and
oxysterols [17] the possible effects of oxidation end products of
cholesteryl esters have been largely ignored in the literature. Oxidation
of lipids containing polyunsaturated fatty acids is quite complex and
results in a plethora of products [16]. One of the end products of oxida-
tion of cholesteryl-esters of polyunsaturated fatty acids is the family of
cholesteryl hemiesters [18]. We decided to examine this group of com-
pounds as possible etiological agents of atherogenesis and recently
showed [18] that a single compound of this chemical family, cholesteryl
hemisuccinate (ChS),when incorporated into native LDL (Nat-LDL) par-
ticles and presented tomacrophages in vitrowas sufﬁcient tomimic two
important features of the fate of macrophages exposed to Ox-LDL:
1) Cells exposed to ChS-LDL irreversibly accumulate undigested lipid
in enlarged lysosomes; and 2) ChS is cytotoxic and provokes apoptotic
cell death.
While the toxicity of Ox-LDL and some of its oxidized lipids to
macrophages has been well documented, the expansion and malfunc-
tion of the lysosomal compartment in macrophages in the initial stages
of atherogenesis have been largely unexplored [4,19]. In this work we
examine the effects of long-term sub-toxic exposure of macrophages
to ChS-LDL (Nat-LDL loaded with ChS), on lysosome morphology and
function. Similar to our earlier work on this subject [18], ChS was used
as a model of the cholesteryl-hemiester family of compounds that
are expected to be produced from polyunsaturated fatty acid esters
of cholesterol. The work has been extended to an in vivo model by
studying the effects of ChS, presented as part of the diet, on zebraﬁsh
larvae.
We show that ChS-LDL, at sub-lethal concentrations, induce forma-
tion of enlarged lysosomes in macrophages in vitro. The degradative
and exit capacity of endocytic cargo by the lysosomes is inhibited.
These outcomes seem to be correlated with accumulation of ChS in
the lysosomal membranes and an increase in lysosomal luminal pH.
ChS-LDL also trigger a pro-inﬂammatory response in mouse primary
bone marrow-derived macrophages (BMDM). Finally, by enriching the
diet of zebraﬁsh larvae with ChS it is possible to mimic the in vitro
phenotypes observed, namely, the intravascular lipid accumulation,
the inﬂammation-induced inﬁltration of myeloid cells in the caudal
vein, and also larval death.2. Materials and methods
2.1. Chemicals and antibodies
Cholesteryl hemisuccinate and dextran (mol wt 9000–11,000) were
from Sigma. POPC and cholesterol (FC) were from Avanti Polar Lipids
(Alabaster, AL). [3H]-Cholesterol was from GE Healthcare. The other
chemicals used were of analytical grade from local sources. Bodipy
493/503 (4,4-Diﬂuoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-
Indacene), Bodipy FL C5-lactosylceramide (LacCer), Dextran Alexa
Fluor® 546, BSA-Texas Red®, DQ™ Red BSA and LysoTracker® Red
DND-99 were from Molecular Probes. DAPI was from Fluka. The anti-
mouse (ABL-93) Lamp-2 antibody was from the Developmental Studies
Hybridoma Bank, (University of Iowa, Iowa City, IA). Filipin and the
monoclonalmouse anti-EEA1 antibodywere fromSigma. Secondary an-
tibodies were fromMolecular Probes or from Jackson Immunoresearch.2.2. LDL isolation and ChS incorporation
Human bloodwas collected from healthy volunteers at CNC, Univer-
sity of Coimbra and CEDOC, NOVA Medical School. Written informed
consent was obtained from all volunteers and approved by the Ethical
Review Board of Faculty of Medicine of University of Coimbra and
NOVA Medical School. LDL were isolated as described previously [20].
ChS-LDL were prepared by incubating Nat-LDL with ChS-POPC (70:30)
100 nm diameter unilamellar liposomes as was described in [18].
2.3. Cell culture
RAW 264.7 cells (ATCC) were maintained in DMEM and cultivated
as described in [18]. BMDM were obtained from femurs and tibias of
8–10 week old C57BL/6 mice from Charles River and all animal proce-
dures were reviewed and approved by DGAV, Portugal. Monocytes
were differentiated into BMDM by culturing plated cells for 7 days in
DMEM supplemented with 10% L929-cells conditioned medium
(LCCM) in a humidiﬁed incubator at 37 °C under 5% CO2 atmosphere.
The assays were performed with BMDM cultures on day seven.
2.4. Zebraﬁsh maintenance and feeding
Zebraﬁsh lines were maintained in accordance with Institutional
and National animal care protocols, in a re-circulating system at 28 °C
on a 14-hour-light, 10-hour-dark cycle. Wild-type (AB) and Pu.1:EGFP
(pU1::Gal4, UAS::GFP) zebraﬁsh embryos were obtained by in vitro
fertilization and kept in E3 zebraﬁsh embryo medium at 28 °C until
reaching the desired developmental stage. Zebraﬁsh larvae were fed
twice a day during 10 days, starting at the 5 days post-fertilization,
with normal diet (from Mucedola, control), FC-enriched (normal food
supplemented with 4% FC, w/w, or 52 μmol per gram of food), or
ChS-enriched diet (normal food supplemented with 5% ChS w/w, or
52 μmol per gram of food). The food was prepared as described in
[21]. To visualize lipid accumulation in the vessels, the food was also
supplemented with 10 μg/g of red ﬂuorescent cholesteryl ester
(CholEsteryl BODIPY® 542/563 C11, from Molecular Probes).
2.5. Cell toxicity
In RAW cells, cell toxicity was measured by the MTT assay as previ-
ously described [22]. For BMDM the MTS assay was used as previously
reported [23].
2.6. ChS toxicity to zebraﬁsh larvae
Zebraﬁsh survival was assessed on the 5th day post-fertilization fed
larvae, fed with the different diets for 10 days. Larvae were fed twice a
day with different concentrations of FC and ChS. Thirty ﬁve larvae
were placed in each test chamber for each food condition. Dead larvae
were removed daily. Larval death was expressed as a fraction of the
total number of individuals subjected to a given condition and
compared to a control population subjected to a normal diet.
2.7. ChS uptake
After incubating RAW cells with 3H-ChS-LDL or Nat-LDL at 37 °C,
cell-associated radioactivity and total cell protein were measured as a
function of time in the macrophages.
2.8. Lysosomal degradation of BSA
The lysosomal capacity to hydrolyze cargo was assessed by incubat-
ing cells, treated for 10 days with 16.5 μg/mL of ChS-LDL or Nat-LDL,
with 20 μg/mL of DQ-BSA (stock 1 mg/mL in PBS) for 3 h in medium
without serum, after which cells were washed and the ﬂuorescence
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(Molecular Devices) with excitation at 590 nm and emission at
620 nm. The total cellular protein content was measured by BCA as
described below and the results were expressed as relative ﬂuorescence
intensity/mg of cell protein.2.9. Cargo exit from the lysosomes towards the Golgi
Cellswere treated for 10 dayswith 16.5 μg/mLof ChS-LDL orNat-LDL
were incubated with BODIPY-LacCer (2.5 μM) in DMEMwith 1% FBS for
45 min and LysoTracker-Red (200 nM) for 15 min at 37 °C. Cell surface
ﬂuorescence of LacCer was removed by washing the cells 3 times with
10% serum. Cells were followed under a confocal microscope for 3 h at
37 °C in RPMI with 10 mM Hepes and 10% FBS. Z-stack images were
obtained for both dyes for co-localization analysis using ImageJ with
JACoP plugin.2.10. Lysosome pH measurement
Lysosomal pH was measured in cells incubated overnight simulta-
neously with dextran conjugated with pHrodo and dextran conjugated
with Alexa Fluor 647 (50 μg/mL of each). The dextran-containing cell
culture medium was removed, cells were washed with fresh culture
medium and analyzed by ﬂuorescence microscopy after 3 h in
dextran-free medium. The acquisition settings were not changed
between different samples. To measure the ﬂuorescence intensity
ratio between pHrodo and Alexa Fluor 647 within the lysosomes, the
organelleswere delimited and theﬂuorescence intensitywas quantiﬁed
through the ImageJ software. Given that the ﬂuorescence intensity of
Alexa Fluor 647 does not change between pH 4 and pH 8 (Supplemen-
tary Fig. 2A) whereas that of pHrodo does, and that both probes are
internalized to the same extent (Supplementary Fig. 2B), the relative
ﬂuorescence intensity of pHrodo measured is an indicator of the lyso-
somal pH. To verify that Alexa Fluor 647 ﬂuorescence was not affected
with pH its ﬂuorescence was measured in 0.2 M sodium acetate buffer
between pH 3.5 and pH 7.5 using a Zenyth 3100 microplate reader
from Anthos.2.11. Filipin staining and binding experiments
After incubation of cells with 16.5 μg/mL of ChS-LDL or 16.5 μg/mL
Nat-LDL for 10 days, cells were ﬁxed and then incubated with Filipin
(25 μg/mL in PBS) for 30min at RT. The cellswere observed under a con-
focal microscope.
The capacity of Filipin to associate with FC and ChSwas evaluated by
absorption spectroscopy [24]. A 50 μM aqueous solution of Filipin was
incubated with different POPC-FC (1:1) and POPC-ChS (1:1) large
unilamellar liposomes (LUVs) overnight, at RT. Absorption spectra
were obtained using the corresponding Filipin-free lipid suspensions
as blanks. Filipin-sterol association curves used the absorbance ratio
(Abs320/Abs356) as a function of sterol concentration (FC or ChS) in the
system and were ﬁtted with theoretical curves using the Hill equation.2.12. Cytokine quantiﬁcation
BMDM plated in a 24-well plate were incubated with 200 μg/mL of
ChS-LDL or 200 μg/mL Nat-LDL for 24 h. Cells were washed and left
unstimulated or stimulated with 20 ng/mL of LPS during 24 h. After
this time point, TNF-α, IL-10, IL-1β and IL-6 secretion were measured
by ELISA in supernatant of stimulated macrophages. To calculate the
cytokine concentration in the samples, optical density values were
compared with a standard concentration calibration curve, using a 4
parameter logistic nonlinear regression model.2.13. Staining, image acquisition and analysis
RAW cells were grown on 24- or 48-well plates and ﬁxed with 4%
PFA for 60min followed by quenching of the aldehyde groups with gly-
cine or ammonium chloride and permeabilized with methanol for
LAMP-2 staining or with Triton X100 for anti-EEA-1 antibody staining.
Cells were then incubated with the primary antibodies at RT for 1 h,
washed, and ﬁnally incubated with the secondary antibodies conjugat-
edwith a ﬂuorophore for 1 h. Sampleswere ﬁxed and analyzed by using
a Zeiss Confocal microscope.
For lipid visualization in zebraﬁsh, larvae were euthanized using
cooled 4% PFA and mounted in mounting media prior to imaging with
Zeiss LSM710 Confocal microscope. Lipid accumulation was measured
by delineating ﬂuorescent deposits area with ImageJ software. For
quantiﬁcation of myeloid cells present in the caudal vein, PU.1:EGFP
transgenic zebraﬁsh were used; GFP positive cells were determined
from an approximately 9000 μm2 segment of the vasculature.
For Oil Red-O staining, larvae were ﬁxed with 4% PFA and rinsed
three times with PBS containing 0.5% Tween-20 (PBS-T) as previous
described [25]. Brieﬂy, larvae were stained with Oil Red in 60%
isopropanol, prepared from a stock solution at 0.5% w/v in 100%
isopropanol for 15 min. They were then rinsed twice with 60%
isopropanol, for 5 min and ﬁnally with PBS-T.
2.14. Western blot
Cells were treated as described in the ﬁgure legends. Cell lysates
were resolved by sodium dodecyl sulfate-polyacrylamide gel by
electrophoresis (SDS-PAGE), and transferred electrophoretically to
polyvinylidene diﬂuoride (PVDF) membranes as previously described
[26].
2.15. Protein assay
The protein content of cell extracts was measured by the
bicinchoninic acid (BCA, Pierce) or by a modiﬁed Lowry method
(BioRad) assay using bovine serum albumin as a standard.
2.16. Statistical analysis
Results are expressed as the mean ± standard error of the mean
(SEM). Statistical signiﬁcance was assessed by one or two-way ANOVA
with a Bonferroni post-test. A p value of 0.05 was considered to be sta-
tistically signiﬁcant.
3. Results
3.1. Long-term exposure to sub-toxic ChS-LDL concentrations caused
lysosome enlargement in macrophages
Atheroma formation in vivo is a very slow pathological process, de-
veloping over many years and often decades, initiated by formation of
irreversible foam cells from macrophages that invade the vasculature.
The acute toxic effects of ChS on macrophages, examined in our previ-
ouswork [18] include irreversible lipidosis, some enlargement of the ly-
sosomes and apoptotic cell death. However, acute toxicity cannot be the
only determinant in the development of atheromata. We, therefore,
assessed the effect of long-term exposure of macrophages in vitro to
sub-toxic concentrations of ChS upon lysosomes of the cells. To deter-
mine suitable ChS concentrations for our experimental purposes, RAW
264.7 macrophages (hereafter referred to as RAW cells) were exposed
to different ChS-LDL concentrations for twenty days as shown in
Fig. 1A. Henceforward, any reference to the concentration of “ChS-LDL”
implies the ChS concentration in the cell culture medium, the ChS hav-
ing been loaded into Nat-LDL particles at a ratio of 1000 molecules of
ChS per LDL particle as previously described in detail [18]. LDL was
Fig. 1.Viability of RAWmacrophages exposed for twenty days to ChS-LDL is not affected. RAWcellswere exposed to different concentrations of ChS-LDL andwere followedduring20days.
Nat-LDL were used as control. A) Shows cell viability assessed by the MTT assay and expressed relative to the viability of control cells exposed to Nat-LDL. B) Shows the incorporation of
intracellular radioactivity as a function of time when RAW cells were exposed to different concentrations of 3H-ChS-LDL as indicated in the graph. After incubation the cells were acid
washed and scraped. The radioactivity and protein were quantiﬁed as described in the Materials and methods section. Values are mean ± SEM of three separate experiments.
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reﬂect any physiological relevance. Our previous work [18] had shown
that acetylated-LDL or phosphatidylcholine liposomes are equally effec-
tive carriers for the ChS. The cell cultures were split every two days and,
to avoid LDL oxidation due to reactive oxygen species produced by RAW
cells, fresh ChS-LDL were added at each splitting. Cell viability, assessed
by theMTT assay, was expressed as percentage of the viability of control
cells exposed to Nat-LDL that were used in all in vitro experiments
described below. Cell proliferation rates were evaluated by counting
the cells at each splitting and examining for 5-ethynyl-2′-deoxyuridine
incorporation [27] (data not shown). No differences were observed
between untreated cells and those treated with Nat-LDL. The three dif-
ferent ChS-LDL concentrations tested were not toxic during the experi-
mental time (Fig. 1A). To ensure that ChS-LDL were being internalized,
RAW cells were treated under the same conditions with 3H-ChS-LDL
and the intracellular radioactivitywas examined as a function of incuba-
tion time (Fig. 1B). For all concentrations tested, radioactivity accumu-
lated within the cells in a ChS-LDL concentration-dependent manner
and was saturable within the ﬁrst eight days of incubation (Fig. 1B).
We concluded that, at the concentrations tested, ChS-LDL were being
internalized by the cells without loss of cell viability.
Taking into account the results described, further experiments used
ChS-LDL at a ChS concentration of 30 μM. RAW cells were exposed toChS-LDL for 20 days and lysosomal area andmorphology were assessed
as a ﬁrst evaluation of lysosomal function. The ﬁrst observation was the
appearance of large lysosomal structures. The size of the lysosomeswas
quantiﬁed by measuring the area of LAMP-2-positive structures in con-
trol and ChS-LDL-treated cells (Fig. 2A). Single 0.419 μm thick slices at
the maximal cell perimeter were quantiﬁed for each case.
Lysosome area in ChS-LDL treated cells (n=50 cells) was strikingly
higher than in control cells (n = 55 cells) and ~40% of the LAMP-
positive organelle area was due to organelles with an area bigger than
6 μm2 (Fig. 2A, D and E). This feature was not observed in macrophages
incubated with Nat-LDL (Fig. 2A–C). Importantly, the number of
lysosomes per cell was similar in control and ChS-LDL-treated cells. All
LAMP-2-positive structures observed in ChS-LDL were not decorated
with EEA-1, a marker for early endosomes (Fig. 2F–G). Thus, the large
vacuolar LAMP-2-positive organelles, whose formation was induced
by exposure to sub-toxic concentrations of ChS-LDL, were not hybrid
organelles of the endocytic compartment. To conclude this set of
experiments and to ensure that lysosomal biogenesis was not affected
by ChS-LDL treatment we performed a Western blot to assess LAMP-2
protein levels. As shown in Fig. 2H, LAMP-2 levels were similar in cells
incubated with Nat-LDL and ChS-LDL. These results suggest that sub-
toxic concentrations of ChS-LDL induced the formation of enlarged lyso-
somes in RAWmacrophages without changes in their biogenesis.
Fig. 2.RAWmacrophages exposed to sub-toxic concentrations of ChS-LDL exhibit lysosomal enlargement. RAWcellswere treated for 20 dayswith 30 μMChS-LDL (corresponding to 16 μg
ApoB/mL), or Nat-LDL (16 μg ApoB/mL). A) Shows the fraction of total LAMP-positive organelles as a function of individual Lamp-positive organelle area. 55 cells exposed to Nat-LDL and
50 cells exposed to ChS-LDLwere used to obtain these results. B) is a DIC image and C) is the corresponding LAMP-2-stained image of RAW cells incubatedwith Nat-LDL. D) and F) are DIC
images of RAW cells incubated with ChS-LDL and E) and G) are the corresponding LAMP-2 and EEA-1-stained images, respectively. All panels show confocal single slice images. Arrows
point to the vacuoles. Bars, 10 μm. H) Shows LAMP-2 protein levels in lysates of cells treated with Nat-LDL or ChS-LDL. GAPDH was used as loading control.
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endocytic cargo
Since lysosomes play a central role in receiving and degrading mac-
romolecules from the endocytic membrane-trafﬁcking pathways we
examined the effect of ChS in lysosomal degradation of endocytic
cargo. Supplementary Fig. 1 shows that neither uptake nor transport
of endocytic cargo (BSA conjugated with Texas Red) to the lysosomes
were affected by exposure to ChS-LDL when compared to the control
(Nat-LDL). Our next step was to verify whether there was efﬁcient deg-
radation of endocytic cargo in the ChS-treated-cells as compared with
the control cells. As endocytic cargowe used DQ-BSA, a ﬂuorogenic sub-
strate for lysosomal proteases. Because this cargo is heavily labeledwith
Bodipy, a strong ﬂuorescence quenching effect is observed. However,
upon enzymatic cleavage of the DQ-BSA to dye-labeled peptides in the
acidic lysosomal compartments this quenching is relieved, producing
brightly ﬂuorescent products. As shown in Fig. 3A–E, the rate of degra-
dation of DQ-BSA by the lysosomal proteases was signiﬁcantly slowerin RAW cells exposed to ChS-LDL as compared to controls, suggesting
that the catalytic activity of this organelle was affected.
To assess whether lysosomal exit capacity contributed to lysosomal
enlargement in cells treated with ChS-LDL we measured the egress of
Lactosylceramide (LacCer) conjugated with Bodipy towards the Golgi.
Glycosphingolipids are known to be internalized by endocytosis in a
clathrin-independent, caveolae-related mechanism. LacCer, which is
not recycled to the PM, is transported to lysosomes and from there to
the Golgi apparatus [28,29]. RAW cells that had been previously ex-
posed to ChS-LDL were incubated with LacCer and their lysosomes
stained with LysoTracker®. The kinetics of exit of the LacCer from
lysosomes towards the TGN were followed by confocal microscopy in
a pulse-chase experiment (Fig. 3F). Similarly to BSA, LacCer delivery to
lysosomes did not appear to be impaired in ChS-LDL treated cells since
the degree of co-localization of LacCer and LysoTracker® was very sim-
ilar in control and treated cells at 30 min chase (Fig. 3F). However, with
increasing time, co-localization of LacCer and lysosomes decreased in
control cells but not in ChS-LDL-treated macrophages. This is clearly
Fig. 3. Lysosomal cargo degradation and exit are inhibited in RAW macrophages treated with ChS-LDL. Macrophages were treated for 20 days with 30 μM ChS-LDL or with the
corresponding amount of Nat-LDL. A) Time-course of DQ-BSA degradation in RAW cells exposed to Nat-LDL and ChS-LDL. B)–E) Representative ﬂuorescence images of the results
obtained in A) at 250 min. B), C), control cells; D), E), cells treated with ChS-LDL. B) and D) are ﬂuorescence images showing the degraded DQ-BSA C) and E) are ﬂuorescent images
showing the degraded DQ-BSA merged with the corresponding DIC images. Bars, 10 μm. In F)–L), Cells were treated as before and then incubated with BODIPY-LacCer and LysoTracker
Red (to visualize the acidic organelles). F), Overlap quantitation of BODIPY-LacCer and LysoTracker. Colocalization was calculated in a pulse chase experiments for N100 cells using the
Manders (M1) coefﬁcient from JACoP plugin (ImageJ). Data represent the mean ± SEM of three independent experiments. Statistical signiﬁcance was assessed by a one-way ANOVA
with a Bonferroni post-test: *, p b 0.05. G)–L), show representative ﬂuorescence images at 180 min chase. G)–I), Cells treated with Nat-LDL; J)–L), Cells treated with ChS-LDL. G) and
J), BODIPY-LacCer; H) and K), LysoTracker; I) and L) are the corresponding merged images. Bars, 10 μm. Zoomed regions of the regions outlined in I) and L) are also shown.
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the regions outlined in panels I and L), suggesting that the LacCer exit
from lysosomes was inhibited in ChS-LDL treated cells.
We, therefore, conclude that while endocytic cargo was taken up
and delivered to the lysosomes at comparable rates in the control and
ChS-LDL-treated cells, lysosomal degradation and cargo exit were
strongly inhibited in ChS-LDL-treated cells. Butwhywere the lysosomal
proteases and cargo exit in ChS-LDL-treated cells affected? To answer
this question we measured the lysosomal luminal pH and assessedwhether ChS, a non-hydrolysable cholesteryl hemiester [18], was
accumulated in lysosomal membranes.
3.3. ChS-LDL exposure caused alteration of lysosomal pH
Lysosomal enzymes require an acidic pH to function properly.
Failure to maintain a low pH within the lysosomes would inhibit the
lysosomal cargo hydrolysis. We, therefore, measured the lysosomal
luminal pH. Cells (Nat-LDL treated controls and ChS-LDL-treated)
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Fluor 647 (whose ﬂuorescence is not affected by pH in the range be-
tween 4 and 8) and with the pH-sensitive pHrodo dye (which has a
pKa ≈6.8) (Supplementary Fig. 2A). Like the other endocytic probes
used above, the uptake of dextran, a ﬂuid phase marker, was not affect-
ed by ChS (Supplementary Fig. 2B). Changes in pH were measured by
quantifying the ratio of emission at two different wavelengths 584
and 645 nm for pHrodo and Alexa Fluor 647, respectively. Fig. 4A
shows that the ﬂuorescence intensity of pHrodo relative to the ﬂuores-
cence intensity of Alexa Fluor 647 is decreased in cells treated with
ChS-LDL compared with control cells. Considering the expected ratio
(for equal internalization of the two ﬂuorescent dextrans) and the pH-
titration curves for pHrodo and Alexa Fluor 647 (Supplementary
Fig. 2A), a rough estimate of the lysosomal pH in ChS-treated macro-
phages is ≥6, a signiﬁcant rise in lysosomal pHwith ChS-LDL treatment.
Since optimal lysosome function requires the ability to maintain an
acidic pH, typically between 4.5 and 5.0 [30], the inhibition of cargo
degradation can be explained, at least in part, by changes in lysosome
pH and subsequent impairment of lysosomal enzyme activity.
We enquired why ChS-LDL exposure could change the lysosomal lu-
minal pH. When RAW cells were exposed to ChS-LDL and stained with
Filipin, a dye used to stain FC, the membrane of the enlarged lysosomes
were stained brightly (Fig. 4D and E), similar to the plasmamembranesFig. 4. ChS accumulates in lysosomal membranes and leads to pH changes. RAWmacrophages w
dextran labeledwith pHrodo and dextran labeledwith Alexa Fluor 647, both simultaneously int
were quantiﬁed. ***, p b 0.001. B)–E), cells were subjected to Filipin staining for FC/ChS detection
DIC images, C) and E) are the corresponding Filipin-staining images. In D and E) arrows point to
large unilamellar liposomes of POPC-FC (1:1) and POPC-ChS (1:1). The graph shows the experim
line) or ChS (⋄, dashed line) and the lines are theoreticalﬁts of the data to theHill equation. The a
ChS complex, with a Hill coefﬁcient of 1.7 in both cases.of the control and ChS-treated cells (Fig. 4B–E) which are known to
contain FC.
Filipin is used as a histochemical stain for FC [24] but there is no re-
port demonstrating that this probe is also able to stain ChS. We showed
in Fig. 4F that Filipin associates with FC and ChS in liposomes containing
these sterols in a similar manner. The experimental data in Fig. 4F was
ﬁtted with the Hill equation with dissociation constants for the Filipin-
FC and Filipin-ChS complexes of 93 and 97 μM, respectively, and Hill co-
efﬁcients of 1.7 for both curves. This suggests that both, the association
free energy and association stoichiometry, of Filipin with FC and with
ChS are identical when these sterols are embedded in phosphatidylcho-
line bilayers. This result may appear to contradict earlier reports that
Filipin associates with FC but not with its esters in bilayer membranes
[24,31]. However, it is also possible that the cholesteryl esters used in
the earlier work (cholesteryl palmitate and cholesteryl acetate, both
neutral cholesteryl esters) were in an isotropic solution state in the bi-
layer midplane and not in the anisotropic state expected for both FC
and ChS when incorporated into membranes. A more detailed study of
the molecular interaction and photophysics of Filipin-sterol complexes
in membranes may be justiﬁed in the future. Thus, the Filipin staining
of the membranes of enlarged lysosomes, combined with the knowl-
edge that ChS is poorly hydrolyzed in cells [18], suggests the presence
of ChS in them. ChS-induced changes in the biophysical properties ofere treated for 20 days with 30 μMChS-LDL or Nat-LDL. A) Fluorescence emission ratio of
ernalized into the cells. ImageJ softwarewas applied to the ﬂuorescent images and 30 cells
. B) and C), cells treatedwith Nat-LDL; D) and E), cells treatedwith ChS-LDL. B) andD) are
Filipin-stained enlarged lysosomes. Bars, 10 μm. F) Association of Filipinwith FC and ChS in
ental (points) absorption intensity ratio (A320/A356) for Filipin as a function of FC (♦, solid
pparent dissociation constant is 93 μMfor the Filipin-FC complex and 97 μMfor the Filipin-
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which in turn inhibit cargo degradation and possibly its exit.
In light of our data demonstrating the development of lysosomal
dysfunction in ChS-LDL-treated macrophages and taking into accountFig. 5. ChS-LDL triggers release of pro-inﬂammatory cytokines. BMDMwere incubatedwith 200
were stimulated for 3 h with 20 ng/mL of LPS or incubated with cell culture medium. In the end
Materials andmethods. The results compare treatmentwith Nat-LDL and ChS-LDL for: A) Cell v
BMDM. ***, p b 0.001.that lysosome dysfunction has recently been proposed to result in an
increased pro-inﬂammatory response [32] we assessed whether the
ChS-LDL were also able to trigger inﬂammation, an important feature
in atherogenesis.μg/mL of ChS-LDL orwith 200 μg/mL of Nat-LDL for 24 h. After supernatant collection, cells
the supernatants were collected. Cytokine secretion was analyzed by Elisa as described in
iability; B) IL-1β secretion; C) TNF-α secretion; D) IL-6 secretion; and E) IL-10 secretion by
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Weassessed the ability of ChS-LDL exposure to induce inﬂammatory
cytokine secretion by BMDM. Speciﬁcally, we determined the levels of
IL-1β, TNFα and IL-6 produced by these cells under conditions
where cell death did not occur (Fig. 5A). Pre-incubation of BMDM
with ChS-LDL for 24 h and further stimulation with LPS for another
24 h induced a 2.5-fold increase of IL-1β release compared to Nat-LDL
or to untreated control cells (Fig. 5A). A similar pattern was also ob-
served for TNF-α and IL-6 (Fig. 5B and C, respectively). Statistically dif-
ferent release of the three pro-inﬂammatory cytokines was always
observed between the cells treated with ChS-LDL and Nat-LDL. In con-
trast, the effect of ChS-LDL on the secretion of the anti-inﬂammatory
molecule IL-10 was not statistically different (Fig. 5D). These results
suggest that exposure of the BMDM to ChS-LDLwas sufﬁcient to induce
an imbalance between pro- and anti-inﬂammatory cytokines
phenocopying what happens in atheroma formation [33–35].
3.5. In vitro and in vivo ChS effects were positively correlated
In previous work [18] we showed that exposure of macrophages to
high concentrations of ChS-LDL for short periods of time (up to 48 h) in-
duced irreversible lipid accumulation in the lysosomal compartment
(lipidosis) followed by cell death. Furthermore, these macrophages,
that normally hydrolyze cholesteryl esters very efﬁciently, were neither
able to hydrolyze cholesteryl esters nor ChS [18]. In this work we show,
for the ﬁrst time, that ChS at subtoxic concentrations induces lysosomal
malfunction and is highly pro-inﬂammatory. To further characterize the
effects of ChS-LDL in vivo, we decided to pursue our experiments in
zebraﬁsh larvae. This in vivomodel has recently been shown to be suit-
able for studying the high-cholesterol diet-induced accumulation of
lipids and myeloid cells in the circulatory vasculature walls [21,36].Fig. 6. ChS induces lipid accumulation in zebraﬁsh larvae. Five-day old zebraﬁsh larvae (AB) we
the diet was also supplemented with 10 μg/g of a red ﬂuorescent cholesteryl ester. A) Larvae
experiments (each experiment with 35 larvae). The error bars indicate the SEM. B) Merge of
fed as described above with 50 μmol of FC or ChS/g of food. Fluorescent lipid deposits were ob
bars, 20 μm. C) Graph showing the area of the lipid structures in the zebraﬁsh caudal vein. Fl
values and the error bars indicate the SEM; ***, p b 0.001.We started by assessing the percentage of survival of zebraﬁsh lar-
vae fed with a diet enriched in ChS. As controls, we used ﬁsh larvae
fed with a normal diet (negative control) and a diet enriched in FC
(positive control). In all cases larvae were fed for 10 days, starting at
5 days post-fertilization with the same molar concentration of ChS
and FC. As shown in Fig. 6A, both FC- and ChS-enriched diets decreased
larvae survival in a dose-dependent manner; the ChS-enriched diet
being signiﬁcantly more lethal.
To assess whether ChS was able to induce lipid accumulation in the
caudal vein, we used the zebraﬁsh larvae that survived feeding with a
4% (w/w) FC-supplemented diet (described in the literature as the
amount of dietary FC that is sufﬁcient to induce lipid accumulation in
the caudal vasculature [28]), or a 5% (w/w) ChS-supplemented diet.
(Note that 4% w/w FC and 5%w/w ChS correspond to the same number
of moles of these compounds in the supplemented diet.) The larval diet
was supplemented in all cases with a trace amount of a red ﬂuorescent
cholesteryl ester. As shown in Fig. 6B, ChS- and FC-fed larvae showed
many focal areas of bright red ﬂuorescence, which we interpreted as
lipid accumulation in the vessel wall of the caudal vein. Larvae fed
with a normal diet did not exhibit this behavior. The area of the bright
red ﬂuorescent structures in the vessel walls, obtained by confocal
Z-stacks of the AB zebraﬁsh larvae, was quantiﬁed. The area of the
lipid deposits in the caudal veinwas higher in ChS- than in FC-fed larvae
(Fig. 6C). These results are well correlated with the accumulation of
lipids induced by ChS-LDL in macrophages [18].
As shown above, ChS-LDL was able to induce secretion of pro-
inﬂammatory cytokines in primary macrophages. Since one of the hall-
marks of inﬂammation in atherogenesis is the inﬁltration of myeloid
cells into the blood vessels, we assessed leukocyte accumulation in FC-
and ChS-fed zebraﬁsh vasculature using transgenic PU.1-EGFP zebraﬁsh
in which macrophages and granulocytes express GFP. As before, larvae
were fed with normal, ChS- or FC-enriched diets for 10 days, startingre fed for 10 dayswith normal-, FC-, or ChS-enriched diets. To visualize lipid accumulation
survival as a function of FC (⋄) or ChS (♦) concentration in the diet of three independent
ﬂuorescence (lipid in red) and the corresponding DIC images of caudal vein in AB larvae
served only in the blood vessel wall of larvae fed with a diet enriched in FC or ChS. Scale
uorescent images of 5–10 larvae were quantiﬁed. The horizontal lines indicate the mean
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cruitment of green ﬂuorescent myeloid cells to the caudal vein (Fig. 7),
suggesting accumulation of macrophages and/or granulocytes in the
vascular wall. Comparison of Fig. 7A and B shows that ChS induced a
higher accumulation of myeloid cells than FC in the vasculature of the
transgenic zebraﬁsh larvae. We conclude that ChS induces inﬂamma-
tion in vivo, a result that is well correlated with the in vitro results
(Fig. 5). Additionally, the cells that invade the vasculature are full of
neutral lipids, as visualized by confocal microscopy after Oil-Red
staining (Fig. 7C).
4. Discussion
Physical trapping of LDL particles in the arterial intima followed by
their modiﬁcation is generally understood to be the ﬁrst step in athero-
genesis. In spite ofmuch debate over the past three to four decades as to
the exact nature of the modiﬁcation of the trapped LDL, oxidative mod-
iﬁcation appears to command a majority consensus. Polyunsaturated
fatty acids (PUFA) are among the chemical components of LDL that
are most vulnerable to oxidation. In LDL particles these PUFA appear
as components of phospholipids and esters of cholesterol. Oxidative
scission of PUFA-cholesteryl esters leads to the formation of oxo-esters
of cholesterolwhichhave been identiﬁed in the “core aldehyde” fraction
of ex vivo samples of human atheromata [13] and have long been known
to be components of oxidized LDL [14]. As we have argued earlier [18],
oxo-esters of cholesterol can be expected to be further oxidized to the
corresponding hemiesters of cholesterol. Indeed, these hemiesters of
cholesterol are detectable in the plasma of human blood (W. Vaz et al.,
unpublished results). Work from other laboratories has identiﬁed
them as the components of Ox-LDL that bind to the plasma protein,
β2-glycoprotein-1, resulting in complexes that may be related to
increased acute coronary syndrome risk [37–39].A B
C
Fig. 7. ChS induces myeloid cell recruitment to the vasculature in zebraﬁsh larvae. Five-day-old
10 days. A)Merge of ﬂuorescent and DIC images of the caudal vein of PU.1:EGFP zebraﬁsh larvae
or ChS and were almost absent in the blood vessel wall of larvae fed a normal diet. Scale bars, 2
indicate themean values and the error bars the SEM; *, p b 0.05. **, p b 0.01. ***, p b 0.001. C) PU:
ﬂuorescence). The square in the merged image was zoomed and the green and red channels sIn previous work [18] we had shown that ChS loaded into native,
non-oxidized LDL and presented to macrophages in vitro induced
lipidosis in these cells, forming irreversible “foam cells”, and leading to
dose-dependent cell death. In the present work we have shown that
long-term exposure to sub-toxic concentrations of ChS leads to
lysosomal malfunction and an inﬂammatory response in macrophages
in vitro. The lysosomal malfunction is characterized by an expansion of
the lysosomal compartment, unaffected endocytic cargo uptake and
delivery to lysosomes, and a reduction in hydrolytic capacity and exit
of cargo from the lysosomes. The demonstrated accumulation of ChS
in lysosomal membranes of macrophages exposed to ChS-LDL probably
alters their biophysical properties and, consequently, the activity of
V-ATPase, the proton transporter responsible for lysosomal acidiﬁcation
[40]. The resulting increase in lysosomal luminal pH leads to
impairment of cargo degradation and transport across the lysosomal
membrane that together culminate in the formation of large lysosomes.
Lysosomal dysfunction is also a critical step in local inﬂammation in
the vessel wall in atherosclerosis [41]. The observation that ChS
also triggers the production of several pro-inﬂammatory cytokines
including IL-1β, TNF-α and IL-6, previously described to contribute to
formation of atherosclerotic lesions [41,42], correlates well with this
information.
Recently, zebraﬁsh have been proposed as an in vivo model for
studies on atherogenesis [21,36]. The proteins involved in the transport
of dietary fat and lipids and inﬂammatory pathways in zebraﬁsh are
conserved relative to mammals [43–45]. Many of the pro-atherogenic
properties of ChS observed in vitro were also observed in vivo in the
zebraﬁsh model in which ChS was delivered through the diet. Dietary
ChS was more toxic to the zebraﬁsh than FC at the same molar fraction
in the food. Vascular lipid deposition and myeloid cell accumulation in
the caudal vein of zebraﬁsh larvae was observed for both FC- and
ChS-enriched diets but the results were signiﬁcantly more pronouncedPU.1:EGFP zebraﬁsh larvae were fed for 10 dayswith normal-, FC- or ChS-enriched diet for
. Greenﬂuorescentmyeloid cells accumulated in the blood vesselwall of larvae fedwith FC
0 μm. B) Quantiﬁcation of the number of myeloid cells per unit area. The horizontal lines
EGFP larvae after 10 days feedingwere ﬁxed and stained for neutral lipidswith Oil-red (red
eparated to show a representative myeloid cell full of neutral lipids. Scale bars, 10 μm.
220 N. Domingues et al. / Biochimica et Biophysica Acta 1862 (2017) 210–220for ChS- than for FC-fed larvae. Hence the in vivo animal model results
strongly conﬁrm the in vitro observations using macrophage cell
cultures.
4.1. Conclusions
Our achievements provide an important conceptual advance
vis-à-vis the existing knowledge on two of the salient features of
atherosclerosis – lipidosis and inﬂammation. We have shown, for
the ﬁrst time, that a single product of the oxidation of the low den-
sity lipoproteins, ChS, is sufﬁcient to induce both the initiation of
atheroma formation (lipidosis) and exacerbate the pathology (in-
ﬂammation). Simultaneously, we are providing signiﬁcant new
mechanistic insights, showing very clearly that lysosomal malfunc-
tion is an important step in the ChS-induced pathogenic process.
Furthermore, one of the guiding motives of our work is the convic-
tion that identiﬁcation of the chemical etiology of atherogenesis will
permit induction of well-deﬁned pathological states in appropriate
in vitro or in vivomodels in a controlled manner and lead to the subse-
quent identiﬁcation of appropriate pharmacological approaches that
may identify therapeutic agents.
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